How it works
How Potenza RF microneedling heats the skin: monopolar and bipolar modes, 1 and 2 MHz, tip types including the pumping tip, needle depth and energy.
Potenza is a radiofrequency (RF) microneedling system made by Jeisys Medical in Seoul. Fine needles enter the skin to a depth the doctor sets, between 0.5 and 4.0 mm, and release RF heat at their tips. The skin repairs those tiny heated zones with new collagen, which is why Potenza is used mainly for acne scars, enlarged pores and rough texture. A full-face visit takes about an hour, and the trials cited on this site used three or four sessions, four to eight weeks apart.
Written by the Potenza Seoul editorial team and medically reviewed by a Korean Board-Certified Dermatologist (AAD International Fellow · ASLMS member). Last reviewed: .
How it works
How Potenza RF microneedling heats the skin: monopolar and bipolar modes, 1 and 2 MHz, tip types including the pumping tip, needle depth and energy.
How Potenza compares with Morpheus8, Sylfirm X, Scarlet and Genius RF microneedling, and with non-needle Thermage, using FDA records and published trials.
What it treats
Which skin concerns Potenza RF microneedling treats well, which it treats partly, and how strong the evidence is for acne scars, pores, laxity, melasma and rosacea.
Planning
How many Potenza sessions you need, how far apart, what the first week looks like, and aftercare for visitors who fly home soon after treatment in Seoul.
What Potenza RF microneedling costs in Seoul in Korean won, what changes the price, how to budget a full course, and what a clear quote should list.
Can Potenza be combined with Ultherapy, Thermage or Rejuran? What studies show about same-day combinations, sensible spacing, and RF microneedling with exosomes.
What the FDA’s October 2025 safety communication on RF microneedling says, what complaint data show, what Potenza’s FDA record covers, and what to ask a clinic.
What Potenza RF microneedling can do for acne scars: which scar types respond, how many sessions, results from trials, recovery, and when to add other treatments.
Potenza is a medical device, not a facial. It joins microneedling, which makes tiny channels in the skin, with radiofrequency energy, which heats tissue. Because the heat is released at the needle tips, the outer skin is largely spared while the deeper dermis is remodelled. In a human-skin study of a fractional RF device, the heated zones were replaced by new collagen and elastin by 10 weeks.[1]
The maker lists two RF frequencies (1 MHz and 2 MHz), monopolar and bipolar modes, and 18 tip types, from 49-needle arrays to single-needle and needle-free tips (Jeisys product page, checked 18 October 2026). In the United States, Potenza is a Class II device cleared through the FDA’s 510(k) route for “dermatologic and general surgical procedures for electrocoagulation and hemostasis” (FDA 510(k) record K231216, checked 18 October 2026). The details are in how Potenza works.
| Concern | Fit | Why |
|---|---|---|
| Rolling and boxcar acne scars | Good | The use with the most evidence: randomised trials and a 2025 systematic review |
| Enlarged pores and rough texture | Reasonable | Measurable pore improvement after three sessions in a small study |
| Mild skin laxity | Partial | Some firming of mild laxity; marked sagging needs a separate lifting assessment |
| Melasma and rosacea redness | Add-on only | Mixed results from small studies; standard treatment comes first |
| Deep icepick scars | Limited | Narrow, deep scars usually need punch techniques as well |
For acne scars, a review of 16 studies with 481 patients concluded that RF microneedling is likely effective on its own.[2] For enlarged pores, three sessions lowered the average pore grade from 3.55 to 2.59 in a group of 22 patients.[3] The full picture, including melasma and rosacea, is in what Potenza treats.
The FDA lists situations in which microneedling may not be suitable (FDA microneedling devices page, checked 18 October 2026). Tell the doctor if any of these apply to you:
Darker skin tones can be treated. A review of 35 studies in skin types III to VI found a low risk of scarring or lasting pigment change; seven of the studies noted temporary darkening.[4]
Expect redness and faint marks afterwards. The maker says redness usually settles within two to four hours, and in one small study, water loss through the skin peaked on days 1 to 3 and was back to baseline by day 7.[5] See sessions, downtime and aftercare for a day-by-day plan.
Delight Dermatology Clinic in Seoul lists Potenza at ₩350,000 to ₩1,300,000 per session, depending on the area and on whether you book one session or a package. Prices checked 2026-10-18; confirm at consultation. Cost in Seoul explains what drives the range and what a quote should list.
In October 2025 the FDA warned that burns, scarring, fat loss, disfigurement and nerve damage have been reported with some cosmetic uses of RF microneedling. The notice named no brand and called for treatment by licensed, trained providers. Our article on the FDA safety communication explains what it said and what to ask a clinic.
Bibliographic records retrieved from PubMed (U.S. National Library of Medicine).
Hantash BM, Ubeid AA, Chang H, et al. Bipolar fractional radiofrequency treatment induces neoelastogenesis and neocollagenesis. Lasers Surg Med. 2009;41(1):1-9.
Niaz G, Ajeebi Y, Alshamrani HM, et al. Fractional Radiofrequency Microneedling as a Monotherapy in Acne Scar Management: A Systematic Review of Current Evidence. Clin Cosmet Investig Dermatol. 2025;18:19-29.
Huang Y, Zheng H, Wu Q, et al. Efficacy and safety of fractional micro-needling radiofrequency for the treatment of enlarged pores on the cheeks of a chinese cohort: a retrospective study. Lasers Med Sci. 2024;39(1):100.
Syder NC, Chen A, Elbuluk N. Radiofrequency and Radiofrequency Microneedling in Skin of Color: A Review of Usage, Safety, and Efficacy. Dermatol Surg. 2023;49(5):489-493.
Wu X, Zhang Z, Zhu J, et al. Can Microneedle Fractional Radiofrequency System Treatment Impair the Skin Barrier Function in Chinese Patients? A Prospective Clinical Trial. Dermatol Ther (Heidelb). 2022;12(10):2371-2382.